These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 28293092)
21. Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer. Shimura T; Toiyama Y; Tanaka K; Saigusa S; Kitajima T; Kondo S; Okigami M; Yasuda H; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M Anticancer Res; 2015 Sep; 35(9):4633-9. PubMed ID: 26254352 [TBL] [Abstract][Full Text] [Related]
22. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer. Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560 [TBL] [Abstract][Full Text] [Related]
23. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma. Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer. Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101). Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390 [TBL] [Abstract][Full Text] [Related]
26. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma. Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399 [TBL] [Abstract][Full Text] [Related]
27. [Expression of KIF18A in gastric cancer and its association with prognosis]. Wang L; Yang S; Sun R; Lu M; Wu Y; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):585-9. PubMed ID: 27215532 [TBL] [Abstract][Full Text] [Related]
28. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer. Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers. Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas. Chen YB; Hou JH; Feng XY; Chen S; Zhou ZW; Zhang XS; Cai MY J Surg Oncol; 2012 May; 105(6):542-7. PubMed ID: 22095667 [TBL] [Abstract][Full Text] [Related]
32. Prognostic Significances of NEDD-9 and FOXL-1 Expression in Intestinal Type Gastric Carcinoma: an Immunohistochemical Study. Elaidy NF; Harb OA; Mohamed AM; Hemeda R; Taha HF; Samir A; Elsayed AM; Osman G; Hendawy EIE J Gastrointest Cancer; 2021 Jun; 52(2):728-737. PubMed ID: 32794109 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer. Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and prognostic significance of stromal cell derived factor 2 in the patients with gastric cancer. Wang Y; Zheng M; Du S; Wang P; Zhang T; Zhang X; Zu G BMC Gastroenterol; 2024 Sep; 24(1):325. PubMed ID: 39342109 [TBL] [Abstract][Full Text] [Related]
35. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
36. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255 [TBL] [Abstract][Full Text] [Related]
37. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
38. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer. Ren C; Chen H; Han C; Fu D; Wang D; Shen M J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261 [TBL] [Abstract][Full Text] [Related]
39. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer. Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822 [TBL] [Abstract][Full Text] [Related]
40. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer]. Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]